Occlutech completes a private placement of approx.CHF46m. The advisors   

Occlutech Holding, a specialist provider of minimally invasive structural heart disease devices, addressing congenital heart defects, stroke prevention and heart failure, has successfully completed a private placement of Swedish Depositary Receipts (SDRs) worth SEK 450 million (approximately CHF 46 million) to the Fourth Swedish National Pension Fund, Carnegie Private Banking and certain other investors. The purpose of the issue is to support Occlutech’s significant opportunities in the U.S. market, continue to facilitate Occlutech’s growth, as well as to repay maturing loans. 

 Occlutech sells its products in over 85 countries and has a clear growth strategy, both in existing markets and through further global expansion. 

 Carnegie Investment Bank (publ) acted as the sole financial adviser to Occlutech. 

Baker McKenzie acted as the legal adviser to Occlutech as to Swedish and Swiss law in connection with the transaction. The Baker McKenzie Switzerland team consisted of capital markets lawyers Matthias Courvoisier (partner, pictured left), Yves Mauchle (senior associate, pictured right) and Beau Visser (associate) as well as Andrea Bolliger (counsel, tax), Zarina Füglister (associate, corporate) and Anna Zellweger (trainee lawyer).  

FabioAdmin

SHARE